Frequently Asked Questions about Artivion, Inc. (AORT)

Name: Artivion, Inc. (AORT) Institutional Financial Dataset
Creator: Olyth
License: https://olyth.xyz

Question 1

What does Artivion, Inc. (AORT) do?

Accepted Answer

Artivion Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide. The company offers BioGlue, a polymer consisting of bovine blood protein and an agent for cross-linking proteins for cardiac, vascular, neurologic, and pulmonary procedures; cardiac preser...

Question 2

Is Artivion, Inc. (AORT) a good stock to buy?

Accepted Answer

Olyth's institutional analysis of AORT reveals an Altman Z-Score of 3.13 and a Piotroski F-Score of 6/9. These metrics, combined with its 5-year revenue trend ($0.44B most recent), help investors decide if AORT fits their risk profile.

Question 3

What is the current P/E ratio for AORT?

Accepted Answer

As of the latest trading session, Artivion, Inc. (AORT) has a trailing P/E ratio of 171.48.

Question 4

Who is the CEO of Artivion, Inc.?

Accepted Answer

The current Chief Executive Officer of Artivion, Inc. is James Patrick Mackin.

Question 5

What was AORT's revenue for the last 5 years?

Accepted Answer

According to its latest income statements, Artivion, Inc. reported annual revenues of $0.44B (2025), $0.39B (2024), $0.35B (2023), $0.31B (2022), $0.30B (2021) respectively.

Question 6

Does AORT pay a dividend?

Accepted Answer

Artivion, Inc. does not currently pay a dividend to its shareholders.

Question 7

How much debt and cash flow does AORT have?

Accepted Answer

In its latest reporting period, Artivion, Inc. generated $-0.00B in Free Cash Flow against a total debt load of $0.29B.

Question 8

What is the Price-to-Book (P/B) ratio of Artivion, Inc.?

Accepted Answer

The Price-to-Book (P/B) ratio for Artivion, Inc. (AORT) is currently 3.74.

Question 9

What is the Price-to-Sales (P/S) ratio of AORT?

Accepted Answer

Based on trailing twelve-month data, Artivion, Inc. (AORT) trades at a Price-to-Sales (P/S) ratio of 3.82.

Question 10

What is Artivion, Inc.'s Return on Equity (ROE)?

Accepted Answer

Artivion, Inc. (AORT) has a Return on Equity (ROE) of 2.44%, representing its profitability relative to shareholder equity.

Period	Revenue	Gross Profit	Op. Income	Net Income	EPS
2025-12	441.3M	270.5M	26.7M	9.8M	0.22
2024-12	388.5M	248.8M	38.9M	-13.4M	-0.32
2023-12	354M	229.2M	5.7M	-30.7M	-0.75
2022-12	313.8M	202.5M	6.2M	-19.2M	-0.48
2021-12	298.8M	197.5M	8.1M	-14.8M	-0.38

Period	Revenue	Gross Profit	Op. Income	Net Income	EPS
2025-12	441.3M	270.5M	26.7M	9.8M	0.22
2024-12	388.5M	248.8M	38.9M	-13.4M	-0.32
2023-12	354M	229.2M	5.7M	-30.7M	-0.75
2022-12	313.8M	202.5M	6.2M	-19.2M	-0.48
2021-12	298.8M	197.5M	8.1M	-14.8M	-0.38